Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients
Med Page Today
MARCH 21, 2024
(MedPage Today) -- Medicare will cover the weight-loss drug semaglutide (Wegovy) under its Part D drug program for patients with overweight or obesity who have preexisting heart disease and need the drug to prevent heart attacks or strokes, the.
Let's personalize your content